View Older Stories View More Recent Stories

Sep 7, 2023 08:00AM Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment Conference
Aug 31, 2023 08:00AM Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy Congress
Aug 28, 2023 07:00AM Praxis Precision Medicines to Present Analyses of Patient-Focused, Clinically Meaningful Endpoints from Essential1 Study of Ulixacaltamide in Essential Tremor at the 2023 MDS International Congress
Aug 9, 2023 07:00AM Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Aug 8, 2023 07:03AM Praxis Precision Medicines (PRAX) Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for Ulixacaltamide
Aug 8, 2023 07:00AM Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for Ulixacaltamide
Aug 7, 2023 07:07AM Praxis Precision Medicines (PRAX) Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 Study
Aug 7, 2023 07:00AM Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 Study
Aug 3, 2023 04:12PM Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare Conference
Jun 22, 2023 07:00AM Praxis Precision Medicines Announces Closing of Financing and Reiterates Corporate Priorities
Jun 9, 2023 07:03AM Praxis Precision Medicines (PRAX) Announces Plans to Begin Ulixacaltamide Phase 3 in Essential Tremor by Year End After Completing End of Phase 2 Meeting with FDA
Jun 9, 2023 07:00AM Praxis Precision Medicines Announces Plans to Begin Ulixacaltamide Phase 3 in Essential Tremor by Year End After Completing End of Phase 2 Meeting with FDA
Jun 2, 2023 09:00AM Praxis Precision Medicines to Present at the 2023 Jefferies Healthcare Conference
May 11, 2023 07:30AM Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 11, 2023 06:55AM Praxis Precision Medicines (PRAX) Announces Positive Topline Results from PRAX-628 Phase 1 Study
May 11, 2023 06:55AM Praxis Precision Medicines Announces Positive Topline Results from PRAX-628 Phase 1 Study Enabling Best-in-Class Profile
Apr 19, 2023 08:00AM Praxis Precision Medicines to Present at the American Academy of Neurology 2023 Annual Meeting
Apr 17, 2023 08:00AM Praxis Precision Medicines Announces Upcoming Ulixacaltamide Presentations & Events
Apr 6, 2023 09:00AM Praxis Precision Medicines to Present at 22nd Annual Needham Virtual Healthcare Conference
Mar 3, 2023 04:05PM Praxis Precision Medicines to Present at Upcoming Investor Conferences
Mar 3, 2023 07:30AM Praxis Precision Medicines (PRAX) Announces Topline Results from the Essential1 Study of Ulixacaltamide for the Treatment of Essential Tremor and Continued Advancement of Program to Phase 3
Mar 3, 2023 07:30AM Praxis Precision Medicines Announces Topline Results from the Essential1 Study of Ulixacaltamide for the Treatment of Essential Tremor and Continued Advancement of Program to Phase 3
Feb 7, 2023 08:00AM Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Dec 13, 2022 04:07PM Praxis Precision Medicines (PRAX) and UCB Announce Epilepsy Research Collaboration
Dec 13, 2022 04:01PM Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration
Nov 28, 2022 04:05PM Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting
Nov 28, 2022 08:03AM Praxis Precision Medicines (PRAX) to Initiate PRAX-562 Phase 2 EMBOLD Study in DEEs
Nov 28, 2022 08:00AM Praxis Precision Medicines to Advance PRAX-562 Phase 2 Study in Pediatric Patients with Developmental and Epileptic Encephalopathies
Nov 9, 2022 04:01PM Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Nov 7, 2022 09:00AM Praxis Precision Medicines to Present at Upcoming Investor Conferences
Sep 20, 2022 08:30AM Invitae’s Real-World Ciitizen Data Utilized in Praxis Precision Medicines’ PRAX-222 IND Filing
Sep 20, 2022 07:30AM Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing
Sep 7, 2022 04:05PM Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference
Sep 7, 2022 07:33AM Praxis Precision Medicines (PRAX) Provides Updates on Clinical Stage Pediatric Epilepsy Programs
Sep 7, 2022 07:30AM Praxis Precision Medicines Provides Updates on Clinical Stage Pediatric Epilepsy Programs
Aug 8, 2022 04:01PM Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Aug 3, 2022 09:00AM Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference
Jun 6, 2022 07:45AM Praxis Precision Medicines (PRAX) Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder
Jun 6, 2022 07:45AM Praxis Precision Medicines Reports Negative Results from PRAX-114 Phase 2/3 Monotherapy Aria Study in Patients with Major Depressive Disorder
May 23, 2022 09:04AM Praxis Precision Medicines (PRAX) Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone
May 23, 2022 09:00AM Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone
May 11, 2022 09:00AM Praxis Precision Medicines to Present at Upcoming Investor Conferences
May 9, 2022 04:01PM Praxis Precision Medicines (PRAX) Reports Positive Topline Results from PRAX-944 Phase 2a Study
May 9, 2022 04:01PM Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2022 Financial Results
May 9, 2022 04:01PM Praxis Precision Medicines Reports Positive Topline Results from PRAX-944 Phase 2a Study in Essential Tremor Patients
May 4, 2022 09:00AM Praxis Precision Medicines to Present at BofA Securities 2022 Healthcare Conference
May 2, 2022 04:15PM Praxis Precision Medicines to Provide Corporate Update and Report First Quarter 2022 Financial Results on Monday, May 9, 2022
Apr 27, 2022 08:27AM Praxis Precision Medicines (PRAX) to Showcase Targeted Epilepsy Portfolio
Apr 27, 2022 08:25AM Praxis Precision Medicines Showcases Largest Targeted Epilepsy Portfolio in Industry at 2022 Epilepsy Day
Apr 13, 2022 08:00AM Praxis Precision Medicines to Host Epilepsy Day on April 27, 2022
View More Recent Stories View Older Stories